Aug 18, 2025
Labcorp Launches First FDA-Cleared Blood Test for Alzheimer's Disease
Jul 30, 2025
Labcorp Introduces Test Finder, a First-of-Its-Kind Generative AI Tool to Simplify Lab Test Search
Jul 29, 2025
Labcorp Achieves IVDR CE-Marking for PGDx elio™ tissue complete in the EU
Jun 18, 2025
Labcorp Launches Labcorp Whole Health Solutions to Support Holistic Care
Apr 23, 2025
Labcorp Launches Molecular Residual Disease and Liquid Biopsy Solutions
Apr 02, 2025
Labcorp Launches First-of-its-Kind Immunoassay to Accelerate Path to Diagnosis of Alzheimer's Disease
Feb 24, 2025
Labcorp Announces Clinical Availability of Liquid Biopsy Test to Guide Personalized Treatment Plans for Patients with Advanced Solid Tumors
Jan 10, 2025
Labcorp to Speak at the 43rd Annual J.P. Morgan Healthcare Conference
Jan 08, 2025
Labcorp to Announce Fourth Quarter Financial Results on February 6, 2025
Jan 08, 2025
LABCORP DECLARES QUARTERLY DIVIDEND
Oct 10, 2024
Labcorp Expands Sexually Transmitted Infection (STI) Test Offerings with Rapid Syphilis Test
Aug 05, 2024
Labcorp Finalizes Acquisition of Select Assets of Invitae
Aug 02, 2024
Labcorp Receives FDA De Novo Marketing Authorization for PGDx elio(TM) plasma focus Dx
Jul 30, 2024
Labcorp Expands Collaboration with Ultima Genomics to Advance Whole Genome Sequencing Applications and Oncology Testing Capabilities
Jun 17, 2024
Labcorp Launches Global Trial Connect to Accelerate Clinical Trials
Jun 03, 2024
Labcorp Announces New Strategic Service Offerings within Precision Oncology Portfolio
May 30, 2024
Labcorp to Present Multiple Abstracts across Precision Oncology at the 2024 ASCO Annual Meeting
May 15, 2024
Labcorp Introduces First Trimester Screening Test to Assess Preeclampsia Risk during Pregnancy
May 15, 2024
Labcorp Introduces First Trimester Screening Test to Assess Preeclampsia Risk during Pregnancy
May 07, 2024
Invitae Receives Court Approval for Sale to Labcorp